The first vaccine was given to Dr Ananda Wijewickrema, a specialist at the hospital. The hospital staff was then vaccinated, Colombo Page reported.
"Made in India vaccine was administered in various hospitals in Colombo. This drive was formally launched at the National Institute of Infectious Diseases. Hon'ble MOS Dr. Sudarshini Fernandopulle, High Commissioner and various other dignitaries attended the event," Indian High Commission in Sri Lanka tweeted.
Last week, Sri Lanka's drug regulatory body -- National Medicines Regulatory Authority (NMRA)--gave a go-ahead to Oxford Astrazeneca's vaccine.
The AstraZeneca-Oxford Covishield vaccine developed in the UK is manufactured by the Serum Institute of India (SII).
India on Thursday sent a total of 5 lakh doses of COVID-19 vaccines to Sri Lanka under the "Vaccine Maitri" initiative.
After receiving the consignment of vaccines, Sri Lankan President Gotabaya Rajapaksa tweeted: "Received 500,000 COVID-19 vaccines provided by people of India at BIA today (28). Thank you! PM Shri Narendra Modi and people of India for the generosity shown towards People of Sri Lanka at this time in need."
Sri Lanka plans to first vaccinate about 150,000 health personnel and 120,000 tri-forces, police and other security personnel, who are in the frontline fighting against the virus.
Vaccinations will be conducted at Colombo National Hospital, Colombo North and Colombo South Teaching Hospitals, Mulleriyawa Base Hospital, Homagama Base Hospital and National Institute of Infectious Diseases, Sri Lankan Ministry of Health said.
Sri Lanka has recorded over 61,000 Covid-19 cases so far. As many as 297 people in the country have succumbed to the virus.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.